Symposium

[S-12] S-12: TDM for central nervous system drugs

2017年9月26日(火) 10:30 〜 12:00 Room E (1F)

Chairs: Kiyofumi Yamada, Japan / Philip Nicholaou Patsalos, UK

+全てマイスケジュールに登録

[S-12-1] TDM for a new class of anti-epileptic drugs

Ikuko Yano (Kobe University Hospital)

[S-12-2] Validation of a high-throughput method for the quantitation of Pregabalin in plasma using ultra-fast SPE-MS/MS

Loralie J. Langman¹, Adam B. Girtman², Paul J. Jannetto³ (1.Mayo Clinic, 2.Mayo Clinic, 3.Mayo Clinic)

[S-12-3] Lamotrigine and valproate drug interactions — the role of pharmacogenomics

Iva Klarica Domjanovic¹, Mila Lovric², Zeljka Petelin Gadze³, Lana Ganoci⁴, Vladimir Trkulja⁵, Nada Bozina⁶ (1.Agency for Medicinal Products and Medical Devices, 2.University Hospital Centre Zagreb, 3.University Hospital Centre Zagreb, 4.University Hospital Centre Zagreb, 5.School of Medicine, University of Zagreb, 6.University Hospital Centre Zagreb)

[S-12-4] Drug monitoring and dose individualisation of anti-epileptic drugs: a role for pharmacometrics

Sven Christiaan van Dijkman¹, Sebastian G. Wicha², Meindert Danhof³, Oscar Della Pasqua⁴ (1.Leiden Academic Centre for Drug Research, 2.Pharmacometrics Group, Uppsala University, 3.Leiden Academic Centre for Drug Research, 4.Clinical Pharmacology and Therapeutics Group, University College London)

[S-12-5] Neonatal PBPK modeling of morphine disposition with OCT1 transporter developmental expression

Chie Emoto¹, David Hahn², Alexander A. Vinks³, Tsuyoshi Fukuda⁴ (1.Cincinnati Children's Hospital Medical Center, 2.Cincinnati Children's Hospital Medical Center, 3.Cincinnati Children's Hospital Medical Center, 4.Cincinnati Children's Hospital Medical Center)